Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

HGF elevation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

HGF amplification (1)

HGF amplification (1)

›

HGF elevation	Hepatocellular Cancer	HGF elevation	Hepatocellular Cancer	cabozantinib tablet Resistant: B - Late Trials cabozantinib tablet Resistant : B	cabozantinib tablet Resistant: B - Late Trials cabozantinib tablet Resistant : B
HGF elevation	Pancreatic Ductal Adenocarcinoma	HGF elevation	Pancreatic Ductal Adenocarcinoma	Resistant: C3 – Early Trials Resistant : C3	Resistant: C3 – Early Trials Resistant : C3
HGF elevation	Renal Cell Carcinoma	HGF elevation	Renal Cell Carcinoma	pazopanib Resistant: C3 – Early Trials pazopanib Resistant : C3	pazopanib Resistant: C3 – Early Trials pazopanib Resistant : C3
HGF elevation	Renal Cell Carcinoma	HGF elevation	Renal Cell Carcinoma	sunitinib Resistant: C3 – Early Trials sunitinib Resistant : C3	sunitinib Resistant: C3 – Early Trials sunitinib Resistant : C3
HGF elevation	Renal Cell Carcinoma	HGF elevation	Renal Cell Carcinoma	sunitinib + pazopanib Resistant: C3 – Early Trials sunitinib + pazopanib Resistant : C3	sunitinib + pazopanib Resistant: C3 – Early Trials sunitinib + pazopanib Resistant : C3
HGF elevation	Melanoma	HGF elevation	Melanoma	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
HGF elevation	Renal Cell Carcinoma	HGF elevation	Renal Cell Carcinoma	cabozantinib tablet Resistant: C3 – Early Trials cabozantinib tablet Resistant : C3	cabozantinib tablet Resistant: C3 – Early Trials cabozantinib tablet Resistant : C3